Z85.030, Personal history of malignant carcinoid tumor of large intestineICD-10-CM
No Prior Auth Required
Code is covered without prior authorization (high confidence)
CGS-J15-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J15
CGS-J15-L39017, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J15
CGS-J18-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J18
CGS-J18-L39017, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J18
WPS-J5-L34614, Colonoscopy and Sigmoidoscopy-Diagnostic
J5
A56394, Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic
J5
WPS-J5-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J5
A58468, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
J5
WPS-J5-L39040, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J5
A58756, Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J5
A59915, Billing and Coding: Pharmacogenomic Testing
J6
NGS-J6-L39995, Pharmacogenomic Testing
J6
WPS-J8-L39040, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J8
WPS-J8-L34614, Colonoscopy and Sigmoidoscopy-Diagnostic
J8
WPS-J8-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J8
A55937, Billing and Coding: Diagnostic Colonoscopy
J9
FIRST_COAST-L39073, Pharmacogenomics Testing
J9
FIRST_COAST-L33671, Diagnostic Colonoscopy
J9
A58812, Billing and Coding: Pharmacogenomics Testing
J9
NOVITAS-JH-L39063, Pharmacogenomics Testing
JH
Ask Backwork about documentation requirements, denial risks, or coverage in your state.